Korea Eases Path to Breakthrough Drugs with Flexible Incremental Cost-effectiveness Ratio
Korea has unveiled major reforms to its national health insurance drug pricing system to improve patient access to innovative medicines, especially for severe and rare diseases. Several weeks ago, the government submitted its “Proposal for Improving the Drug Pricing System” to the... Read More